HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Judi Bryant Selected Research

BX-2819

7/2009Potent triazolothione inhibitor of heat-shock protein-90.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Judi Bryant Research Topics

Disease

2Neoplasms (Cancer)
07/2009 - 05/2005
2Myocardial Infarction
01/2008 - 07/2005
1Multiple Sclerosis
11/2018
1Neoplasm Metastasis (Metastasis)
07/2009
1Ischemic Stroke
01/2008
1Hemorrhage
05/2007
1Thrombosis (Thrombus)
05/2007

Drug/Important Bio-Agent (IBA)

2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2008 - 05/2007
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2018
1Plasminogen Activators (Plasminogen Activator)IBA
11/2018
1tanespimycin (17AAG)IBA
07/2009
1BX-2819IBA
07/2009
1Proteins (Proteins, Gene)FDA Link
07/2009
1Rifabutin (Ansamycin)FDA Link
07/2009
1Adenosine Diphosphate (ADP)IBA
05/2007
1Purinergic P2Y Receptor AntagonistsIBA
05/2007
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2007
1Clopidogrel (Plavix)FDA Link
05/2007
14- (((4- (1- carboxy- 1- methylethoxy)- 7- methylquinolin- 2- yl)carbonyl)amino)- 5- (4- (ethoxycarbonyl)piperazin- 1- yl)- 5- oxopentanoic acidIBA
05/2007
14- ((4- (1- (ethoxycarbonyl)- 1- methylethoxy)- 7- methyl- 2- quinolyl)carbamoyl)- 5- (4- (ethoxycarbonyl)piperazin- 1- yl)- 5- oxopentanoic acidIBA
05/2007
1Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2005
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2005
1Antineoplastic Agents (Antineoplastics)IBA
05/2005
1AgarIBA
05/2005
1Phosphotransferases (Kinase)IBA
05/2005
1PlasticsIBA
05/2005
1Phosphatidylinositols (Phosphatidylinositol)IBA
05/2005

Therapy/Procedure

1Oral Administration
05/2007